# Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly Volunteers

> **NCT01444482** · PHASE1 · UNKNOWN · sponsor: **Isconova AB** · enrollment: 110 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Matrix M
- **BIOLOGICAL:** Seasonal influenza vaccine

## Key facts

- **NCT ID:** NCT01444482
- **Lead sponsor:** Isconova AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2011-11
- **Final completion:** —
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2011-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444482, "Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01444482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*